Adult Primary Care for the Advanced Practice Nurse (D118)

Correct answer: B. Suicide risk assessment is significant as it helps healthcare providers identify patients who may be at risk of self-harm and allows for timely interventions to prevent suicide.

Explanation:

Suicide risk assessment is a critical part of managing Major Depressive Disorder because individuals with depression are at increased risk of self-harm and suicide. Identifying these risks early allows healthcare providers to implement interventions to ensure the safety of the patient, such as hospitalization, therapy, or medication adjustments. It helps healthcare professionals monitor the severity of symptoms and provide timely interventions to prevent tragic outcomes.

Why other options are wrong:

A. Suicide risk assessment is primarily used to evaluate treatment adherence.

While treatment adherence is important, suicide risk assessment focuses on identifying immediate threats to a patient’s safety. It helps identify individuals at risk of self-harm, not just measure how well they are following their treatment plan.

C. Suicide risk assessment is not relevant in the management of Major Depressive Disorder.

This statement is incorrect. Suicide risk assessment is highly relevant in the management of Major Depressive Disorder due to the elevated risk of self-harm or suicide among those affected by the disorder.

D. Suicide risk assessment is only necessary for patients with a history of suicide attempts.

Although those with a history of suicide attempts are at a higher risk, any patient with Major Depressive Disorder should undergo a suicide risk assessment. It is essential to assess all patients for potential risks, regardless of their history.

Correct answer: A. ibuprofen

Explanation:

Ibuprofen and other nonsteroidal anti-inflammatory drugs (NSAIDs) can increase lithium levels in the blood by reducing its renal clearance. This can lead to lithium toxicity, which may cause symptoms such as nausea, tremors, confusion, and kidney dysfunction. Patients taking lithium should generally avoid NSAIDs unless specifically advised by their healthcare provider, and alternative pain relievers should be considered.

Why other options are wrong:

B. oxycodone

Oxycodone is an opioid analgesic that does not significantly interfere with lithium metabolism or excretion. While both drugs may have central nervous system effects, oxycodone does not increase lithium levels or pose a risk of toxicity in the same way that NSAIDs do. However, caution is still necessary when using opioids in patients with mood disorders, as they can contribute to sedation or respiratory depression.

C. tylenol

Tylenol (acetaminophen) is a safer alternative for pain relief in patients taking lithium because it does not affect lithium clearance through the kidneys. Unlike NSAIDs, acetaminophen does not interfere with renal function or cause fluctuations in lithium levels, making it a preferred option for mild to moderate pain management. However, it should still be used responsibly to avoid liver toxicity at high doses.

D. aspirin

Aspirin, although an NSAID, does not significantly impact lithium levels like other NSAIDs such as ibuprofen or naproxen. Studies suggest that aspirin does not reduce lithium clearance, making it a relatively safer option if an NSAID is needed. Nonetheless, patients should still use it cautiously and under medical supervision to avoid potential gastrointestinal side effects.

Correct answer: B. Advise the patient to avoid ibuprofen as it is an NSAID that can increase lithium levels.

Explanation:

Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, can reduce kidney clearance of lithium, leading to increased lithium levels in the blood. Elevated lithium levels can result in toxicity, which may cause symptoms like nausea, tremors, confusion, and even severe neurological effects. Alternative pain relievers like acetaminophen (Tylenol) are generally considered safer for patients on lithium. Patients should always check with their healthcare provider before taking any new medications, including over-the-counter drugs.

Why other options are wrong:

A. Advise the patient to take ibuprofen as it is safe with lithium.

This is incorrect because ibuprofen can increase lithium levels, potentially leading to toxicity. Safer alternatives should be considered.

C. Advise the patient to consult their doctor before taking any medication.

While consulting a doctor is always a good practice, specific guidance on avoiding ibuprofen is essential in this scenario. The patient should be informed about the risks associated with NSAIDs and lithium.

D. Advise the patient to take ibuprofen only if they have a headache.

This option does not address the risk of lithium toxicity. The patient should be advised to use an alternative pain reliever or consult their doctor.

Correct answer: A. Immediate intervention to ensure the patient's safety, including possible hospitalization.

Explanation:

When a patient describes a detailed suicide plan, especially one with highly lethal means readily available, it is critical to act immediately to ensure their safety. This includes considering hospitalization to provide a secure environment, close monitoring, and access to appropriate mental health care. Prompt action can help prevent a potentially fatal outcome, and the patient's immediate safety is the top priority.

Why other options are wrong:

B. Refer the patient to a support group for depression.

While support groups can be helpful, referring a patient with an imminent suicide risk to a support group is inadequate in such a critical situation. Immediate intervention is required to ensure the patient is not left in a vulnerable state.

C. Schedule a follow-up appointment in two weeks.

Scheduling a follow-up appointment in two weeks is far too delayed given the immediate risk of self-harm. Immediate intervention is necessary to address the crisis and prevent harm.

D. Provide the patient with educational materials on coping strategies.

While coping strategies can be helpful, providing them without addressing the immediate risk of suicide is not sufficient. The patient requires immediate intervention to protect their safety before engaging in further therapeutic measures.

Correct answer B. Evaluate the patient's diet and lifestyle, and consider adjusting the lithium dosage.

Explanation:

Weight gain is a common side effect of lithium therapy, and management should begin with a thorough assessment of the patient’s diet, physical activity, and overall metabolic health. The clinician should explore lifestyle modifications, such as dietary changes and increased physical activity, before considering any medication adjustments. If the weight gain is significant and affects the patient’s adherence to lithium, dose modification or switching to an alternative mood stabilizer may be considered.

Why other options are wrong:

A. Refer the patient for weight loss surgery.

Weight loss surgery is not an appropriate first-line intervention for lithium-induced weight gain. The patient should first attempt lifestyle changes and, if needed, medication adjustments under clinical supervision.

C. Increase the lithium dosage to counteract weight gain.

Increasing the lithium dosage does not counteract weight gain. In fact, higher lithium levels can exacerbate metabolic side effects. Instead, a more holistic approach involving dietary and lifestyle modifications should be prioritized.

D. Immediately discontinue lithium treatment.

Abruptly stopping lithium can lead to mood instability and relapse of bipolar disorder. Medication adjustments should only be made under careful clinical supervision, considering the risks and benefits of alternative treatments.

Correct answer: B. Reexperiencing symptoms can lead to significant distress, impair daily functioning, and disrupt relationships.

Explanation:

Reexperiencing symptoms in PTSD, such as flashbacks, intrusive thoughts, and distressing nightmares, can significantly affect a person’s daily life. These symptoms can cause emotional distress, trigger anxiety, and make it difficult to concentrate or engage in social interactions. People with PTSD may avoid certain situations or environments that remind them of the traumatic event, leading to isolation and difficulties in personal and professional relationships. Additionally, these symptoms can contribute to sleep disturbances, heightened irritability, and decreased overall quality of life.

Why other options are wrong:

A. Reexperiencing symptoms only occur during sleep and do not affect waking hours.

This is incorrect because reexperiencing symptoms can occur at any time, not just during sleep. While nightmares are a common feature of PTSD, individuals also experience flashbacks and intrusive thoughts while awake, leading to significant distress and disruptions in daily activities.

C. Reexperiencing symptoms has no impact on daily life activities.

This is incorrect because PTSD symptoms can interfere with work, relationships, and everyday tasks. People with PTSD often struggle with anxiety, hypervigilance, and emotional dysregulation, which can make it difficult to function normally in social and professional settings.

D. Reexperiencing symptoms enhance a person’s memory and focus.

This is incorrect because reexperiencing symptoms typically have a negative impact on memory and concentration. Individuals with PTSD may have difficulty focusing due to hyperarousal, emotional distress, and intrusive thoughts. Rather than enhancing cognitive function, PTSD symptoms can impair problem-solving abilities and memory retention.

Correct answer: D. These medications can increase lithium levels and the risk of toxicity.

Explanation:

NSAIDs (nonsteroidal anti-inflammatory drugs) and diuretics can interfere with the body's ability to regulate lithium levels, leading to an increased risk of toxicity. NSAIDs reduce renal clearance of lithium, causing it to accumulate in the bloodstream. Diuretics, particularly thiazide diuretics, decrease sodium levels, which can result in higher lithium retention and a greater risk of toxicity. Lithium toxicity can cause serious symptoms such as nausea, tremors, confusion, and kidney damage, making it essential for patients to avoid or closely monitor the use of these medications.

Why other options are wrong:

A. These medications enhance the effectiveness of lithium.

This is incorrect because these medications do not improve lithium's therapeutic effect but instead increase its levels to potentially dangerous amounts. Enhanced lithium effectiveness would imply a controlled and beneficial outcome, whereas the reality is that these drugs increase toxicity risk rather than therapeutic benefits.

B. These medications have no effect on lithium levels.

This is incorrect because NSAIDs and diuretics significantly impact lithium levels by reducing its excretion, leading to an increased concentration in the bloodstream. Failure to recognize this interaction can result in lithium toxicity, which may require medical intervention.

C. These medications are used to treat depression.

This is incorrect because NSAIDs and diuretics are not primarily used to treat depression. NSAIDs are used to manage pain and inflammation, while diuretics are prescribed for conditions like hypertension and heart failure. Although lithium is a mood stabilizer used for bipolar disorder, these medications do not contribute to its antidepressant effects and can instead pose serious health risks.

Correct Answer: C. Mood stabilizers and atypical antipsychotics

Explanation:

In the treatment of acute manic episodes in Bipolar Disorder, mood stabilizers (such as lithium or valproate) and atypical antipsychotics (such as olanzapine or risperidone) are the first-line medications. These medications are effective in managing manic symptoms, stabilizing mood, and preventing further episodes. They target mood swings, aggression, and psychosis, which are common in manic episodes.

Why other options are wrong:

A. Antidepressants and benzodiazepines

Antidepressants are generally avoided during acute manic episodes because they can potentially precipitate a manic switch in bipolar disorder. Benzodiazepines are often used for short-term anxiety or sleep issues, but they are not first-line treatments for acute mania.

B. SSRIs and tricyclics

SSRIs and tricyclics are antidepressants and are not typically used as first-line treatments for manic episodes in bipolar disorder. In fact, they may be harmful if used alone in bipolar disorder as they can trigger manic episodes.

D. Stimulants and MAO inhibitors

Stimulants and MAO inhibitors are not appropriate first-line treatments for acute manic episodes in bipolar disorder. Stimulants are generally used for ADHD and MAO inhibitors for depression, but neither is effective for managing manic symptoms in bipolar disorder.

Correct Answer: D. Conduct a thorough risk assessment for suicide.

Explanation:

When a patient with Major Depressive Disorder expresses suicidal ideation, the most critical step is to assess the severity of the risk. A thorough suicide risk assessment helps determine the level of intent, presence of a plan, means, and protective factors. Based on the findings, immediate interventions such as hospitalization, crisis support, or emergency psychiatric care may be necessary. This ensures that the patient receives the appropriate level of care and support to prevent self-harm.

Why other options are wrong:

A. Refer the patient to a psychiatrist without further evaluation.

While psychiatric referral is important, immediate risk assessment must be conducted first. Simply referring without evaluating the urgency of the situation could delay necessary intervention, increasing the risk of harm.

B. Encourage the patient to engage in physical activity.

Although exercise can improve mood, it is not an immediate or sufficient response to active suicidal ideation. The patient requires a thorough risk assessment and crisis intervention rather than lifestyle recommendations alone.

C. Prescribe antidepressants immediately.

While antidepressants are a common treatment for depression, they should not be prescribed without a proper suicide risk assessment. In some cases, antidepressants can increase suicidal thoughts in the early stages of treatment, especially in younger patients. Immediate safety planning and crisis intervention take priority.